Synergistic Vulvovaginitis Treatment System
Legal Citation
Summary of the Inventive Concept
A comprehensive system for treating vulvovaginitis by integrating ozonized olive oil compositions with advanced technologies like AI, IoT, blockchain, and novel materials, enabling personalized, efficient, and secure treatment.
Background and Problem Solved
The original patent disclosed an ozonized olive oil composition for treating vulvovaginitis. However, this composition has limitations in terms of diagnosis, prevention, and supply chain management. The new inventive concept addresses these limitations by synergistically combining the ozonized olive oil composition with distinct technologies, providing a more powerful system for treating vulvovaginitis.
Detailed Description of the Inventive Concept
The system comprises an ozonized olive oil composition with a peroxide value of 50-350 mEq O2/Kg, which is integrated with an AI-powered diagnostic module for identifying the microbial origin of the infection. Additionally, the system may include an IoT-enabled wearable device for monitoring genital tract health, a blockchain-secured supply chain management system for tracking the origin and authenticity of the composition, and a novel nanomaterial-based delivery system for enhancing the composition's therapeutic efficacy. The system enables personalized treatment regimens based on individual patient data using machine learning algorithms.
Novelty and Inventive Step
The new claims introduce a synergistic combination of the ozonized olive oil composition with advanced technologies, which is not obvious from the original patent. The integration of these technologies provides a new, more powerful system for treating vulvovaginitis, offering improved diagnosis, prevention, and supply chain management.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include integrating the ozonized olive oil composition with other advanced technologies, such as robotic-assisted diagnosis or telemedicine platforms. Variations of the system may also include different nanomaterial-based delivery systems or blockchain-secured supply chain management systems.
Potential Commercial Applications and Market
The Synergistic Vulvovaginitis Treatment System has significant commercial potential in the healthcare industry, particularly in the fields of gynecology and infectious diseases. The system's ability to provide personalized, efficient, and secure treatment regimens makes it an attractive solution for healthcare providers and patients alike.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical and medical device technologies focused on gynecological treatments, specifically topical compositions for managing vulvovaginitis and related genital tract infections
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced training in pharmaceutical sciences, biotechnology, or medical engineering, possessing expertise in formulation development, diagnostic technologies, and medical device integration
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies with established pharmaceutical compositions represents a predictable and logical extension of existing medical treatment paradigms. The source patent's ozonized olive oil composition provides a foundational treatment method that naturally invites technological augmentation for improved diagnostic and monitoring capabilities. The proposed variations leverage standard technological integration techniques that would be readily apparent to a skilled practitioner seeking to enhance treatment efficacy and patient outcomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,570 |
|---|---|
| Title | Natural composition for use in gynecology |
| Assignee(s) | ORGANICARE LLC |